Acquired Amegakaryocytic Thrombocytopenia Progressing to Aplastic Anaemia

4Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Acquired amegakaryocytic thrombocytopenia (AAMT) is a rare disorder of the bone marrow characterized by a lack of megakaryocytes and preservation of other cell lines. It can occur due to an intrinsic stem cell defect or secondary to viral infections, autoimmune disorders, lymphoproliferative disorders or environmental toxins. With time, it can progress to aplastic anaemia (AA) and can have a poor prognosis. No standard guidelines exist for the treatment of AAMT progressing to AA. Herein, we report a rare case of AAMT leading to AA and review the handful of cases previously published in the literature.

Cite

CITATION STYLE

APA

Hussain, S. A., Fatima, H., Faisal, H., & Bansal, M. (2022). Acquired Amegakaryocytic Thrombocytopenia Progressing to Aplastic Anaemia. European Journal of Case Reports in Internal Medicine, 9(9). https://doi.org/10.12890/2022_003479

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free